Your Health Plan:
Your Health Plan:
Not SelectedSOLIQUA 100/33 (insulin glargine and lixisenatide) is a biologic prescription drug for treatment of Diabetes Mellitus, Non-Insulin-Dependent. SOLIQUA 100/33 is a combination of glp-1 receptor agonist and insulin analog / insulin analog. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $735-860.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to SOLIQUA 100/33 may include:
